|
|
40
|
0621C
|
PURINETHOL 50MG TAB (ASG/STO) MERCAPTOPURINE
|
MERCAPTOPURINE
|
PURINETHOL
|
25'S
|
A
|
104.38
|
4.18
|
TABLET
|
60
|
TAB
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
41
|
0621C
|
PURINETHOL 50MG TAB (ASG) MERCAPTOP (C)
|
MERCAPTOPURINE
|
PURINETHOL
|
25'S
|
C
|
107.51
|
4.3004
|
TAB
|
60
|
BOX
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
40
|
06319
|
METHOTREXATE 2.5MG TAB (REM/SBI)
|
METHOTREXATE
|
METHOTREXATE
|
10X10
|
A
|
14.79
|
0.15
|
TABLET
|
32
|
TAB
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
40
|
0631AD
|
METHOTREXATE 2.5MG TAB (INP/AHI)
|
METHOTREXATE
|
METHOTREXATE
|
100'S
|
A
|
12.72
|
0.13
|
TABLET
|
32
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
41
|
0631AG
|
ZUVITREX 2.5MG TAB (ZUV) METHOTREXATE
|
METHOTREXATE
|
ZUVITREX
|
100'S
|
A
|
13.32
|
0.1332
|
TAB
|
32
|
BOX
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
41
|
0631D
|
METHOTREXATE 2.5MG TAB (REM)
|
METHOTREXATE
|
METHOTREXATE
|
100'S
|
A
|
14.79
|
0.1479
|
TAB
|
32
|
BOTT
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
40
|
0631Y
|
METHOTREXATE 2.5MG TAB (FSB/ATB)
|
METHOTREXATE
|
METHOTREXATE
|
100'S
|
A
|
7.48
|
0.07
|
TABLET
|
32
|
TAB
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2022-09-30
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
2022-03-30
|
|
|
40
|
0633V
|
METHACOR 25MG/ML INJ (INP/AHI) METHOTREXATE
|
METHOTREXATE
|
METHACOR
|
2ML VIAL
|
B
|
8.70
|
8.70
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
40
|
0633X
|
UNITREXATE 25MG/ML INJ (UBI/RXP) METHOTREXATE
|
METHOTREXATE
|
UNITREXATE
|
2ML VIAL
|
B
|
7.07
|
7.07
|
INJECTION
|
0
|
VIAL
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
41
|
0633Z
|
ZUVITREX 25MG/ML INJ (ZUV) METHOTREXATE (B)
|
METHOTREXATE
|
ZUVITREX
|
2ML VIAL
|
B
|
5.11
|
5.1104
|
VIAL
|
5
|
VIAL
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ANTINEOPLASTICS
|
|
|
|
40
|
0634M
|
METHOTREXATE 25MG/ML INJ (INP/AHI)
|
METHOTREXATE
|
METHOTREXATE
|
20ML VIAL
|
BQ
|
46.43
|
46.43
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
40
|
06351
|
METHOTREXATE 25MG/ML INJ (INP/AHI)
|
METHOTREXATE
|
METHOTREXATE
|
40ML
|
BQ
|
82.12
|
82.12
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
40
|
06417
|
ACCORD MITOMYCIN 5MG INJ (INP/AAL) MITOMYCIN
|
MITOMYCIN
|
ACCORD MITOMYCIN
|
5MG VIAL
|
BQ
|
203.06
|
203.06
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
40
|
0671D
|
UNIBLASTIN 10MG INJ (UBI/RXP) VINBLASTINE
|
VINBLASTINE
|
UNIBLASTIN
|
10MG VIAL
|
BQ
|
54.37
|
54.37
|
INJECTION
|
0
|
VIAL
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
41
|
0671F
|
VINBLASTINE 10MG INJ (KWA) (BQ)
|
VINBLASTINE
|
VINBLASTINE
|
10MG VIAL
|
BQ
|
26.94
|
26.9386
|
VIAL
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
40
|
0681Q
|
UNICRISTINE 1MG INJ (UBI/RXP) VINCRISTINE
|
VINCRISTINE
|
UNICRISTINE
|
1MG VIAL
|
BQ
|
7.07
|
7.07
|
INJECTION
|
0
|
VIAL
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
41
|
06926
|
NEOSTIGMINE 2.5MG/ML INJ (ANT) (BQ)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
10X1ML
|
BQ
|
46.21
|
4.6212
|
AMP
|
0
|
BOX
|
ANT
|
CONCORDIA INTERNATIONAL
|
COL
|
COLLINS LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV/IM/SC
|
0
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
40
|
0692H
|
NEOSTIGMINE 2.5MG/ML INJ (SGH/COL)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
10X1ML
|
BQ
|
17.13
|
1.71
|
INJECTION
|
0
|
AMP
|
SGH
|
SEIGFRIED-HAMELN
|
COL
|
COLLINS LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
40
|
0692J
|
LASTIGMINE 2.5MG/ML INJ (LDP/AHI)
|
NEOSTIGMINE
|
LASTIGMINE
|
5X1ML
|
BQ
|
16.99
|
3.40
|
INJECTION
|
0
|
AMP
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
2022-03-29
|
|
|
40
|
0692L
|
NEOSTIGMINE 2.5MG/ML INJ (MON/PHA)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
5X1ML
|
BQ
|
7.83
|
1.57
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|